What Does NAD+ Do for the Body? A Grounded Longevity Overview

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This page is part of the PlexusDx Education Hub — evidence-based guidance on longevity compounds, peptide science, and the genetic variables behind aging-related biology.

NAD+ shows up constantly in longevity conversations, usually with big promises attached. This page keeps the framing grounded: what NAD+ is discussed as within longevity protocols, how compounds in this space are generally approached, why FDA status varies, and where genetics fit. PlexusDx offers NAD+ through its Longevity Protocols, prescribed by licensed providers.

How NAD+ is discussed in longevity protocols

NAD+ is a compound frequently referenced in the longevity-protocol space, and the PlexusDx Longevity Protocols collection covers the specific compounds it actually offers. For any compound in this category, the honest starting point is that pharmacological mechanisms are described in peer-reviewed literature, while real-world effect sizes vary by indication, dosing, individual factors, and adherence. See the relevant product page for current formulation details.

The areas of biology people focus on

Depending on the specific compound, longevity-related discussion tends to cluster around energy metabolism, antioxidant defense, cognitive performance, and tissue repair. These effects, where they exist, are mediated through specific receptor or enzymatic pathways rather than a single catch-all mechanism. The practical takeaway is to calibrate expectations to clinical literature rather than testimonials, because the gap between the two can be wide.

Why FDA status is not one answer

FDA approval status varies by compound and indication. Some compounds, such as sermorelin and methylene blue, have FDA-approved indications, while most longevity-protocol uses are off-label or compounded. Compounded products are dispensed through licensed 503A pharmacies and are not FDA-approved as branded products. That distinction matters when you are comparing what you read online against what a licensed pharmacy can actually prepare under a valid order.

The genetic terrain behind aging biology

Longevity compounds do not act on a blank slate. Variants in FOXO3, SIRT1, and KLOTHO shape the baseline biology these compounds work through — the upstream metabolic and longevity terrain a clinician is prescribing into. These variants are pathway-level: they describe tendencies, not predictions of response to any specific compound. Knowing that profile is the difference between informed decision-making and trial-and-error.

Where the genetic test fits

Regardless of which longevity-pathway compound you and your provider eventually discuss, the underlying genetic architecture is the same. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FOXO3, SIRT1, and KLOTHO that shape baseline longevity-related biology. Reading that terrain before committing to any protocol turns guesswork into an informed conversation. The test does not predict response to any specific compound; it provides upstream context.

Separating longevity signal from noise

The longevity space moves fast and markets faster, which makes a disciplined reading habit valuable. When you encounter a claim about NAD+ or any related compound, the useful questions are consistent: what does the peer-reviewed literature actually describe about the mechanism, what indication is being discussed, and is the product FDA-approved for that use or prepared through compounding. Those three questions filter out most of the hype on their own.

It also helps to keep expectations proportional. Testimonials describe individuals; clinical literature describes populations with dosing, controls, and measured effect sizes. Calibrating to the latter, and bringing specific questions to a provider, keeps a longevity conversation grounded in what is genuinely known rather than what is simply popular.

Finally, it helps to treat any longevity protocol as a decision made with a clinician rather than a purchase made alone. Because FDA status, formulation, and evidence vary so much across this category, the value of a provider conversation is high. Bringing specific, literature-grounded questions to that conversation is the single most useful habit you can build in this space.

Frequently Asked Questions

What is NAD+ in the context of longevity?

NAD+ is a compound frequently referenced in longevity protocols, with discussion centered on pathways related to energy metabolism and cellular function. Mechanisms are described in peer-reviewed literature, while clinical effect sizes vary. The PlexusDx Longevity Protocols collection lists the specific compounds it offers; see each product page for formulation details.

Is NAD+ FDA-approved?

Approval status varies by compound and indication. Some compounds, like sermorelin and methylene blue, carry FDA-approved indications, while most longevity-protocol uses are off-label or compounded. Compounded products are dispensed through licensed 503A pharmacies and are not FDA-approved as branded products. Discuss compound-specific considerations with your prescribing provider before starting anything.

Does PlexusDx sell NAD+?

PlexusDx offers NAD+ through its Longevity Protocols, prescribed by licensed providers. Its Longevity Protocols collection covers the specific compounds it actually offers. This page is educational, meant to give you grounded context for a conversation with a qualified healthcare provider rather than to recommend any particular longevity compound or protocol.

How does genetics relate to longevity compounds?

The Precision Peptide Genetic Test provides pathway-level context relevant to longevity biology by analyzing variants in FOXO3, SIRT1, KLOTHO, and other genes that shape baseline biology. It does not predict response to any specific compound. Instead, it maps the upstream terrain that informs protocol decisions you make with your provider.

Keep reading across the PlexusDx Education Hub for more evidence-based guidance on metabolic health and precision wellness.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.